These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1084 related items for PubMed ID: 18453527

  • 21. Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England.
    Woodford N, Kaufmann ME, Karisik E, Hartley JW.
    J Antimicrob Chemother; 2007 Jan; 59(1):106-9. PubMed ID: 17090553
    [Abstract] [Full Text] [Related]

  • 22. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains.
    Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppé E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E.
    J Antimicrob Chemother; 2009 Aug; 64(2):274-7. PubMed ID: 19474064
    [Abstract] [Full Text] [Related]

  • 23. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC, Študentová V, Jakubů V, Španělová P, Urbášková P, Žemličková H, Hrabák J.
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [Abstract] [Full Text] [Related]

  • 24. Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain.
    Mora A, Blanco M, López C, Mamani R, Blanco JE, Alonso MP, García-Garrote F, Dahbi G, Herrera A, Fernández A, Fernández B, Agulla A, Bou G, Blanco J.
    Int J Antimicrob Agents; 2011 Jan; 37(1):16-21. PubMed ID: 21075606
    [Abstract] [Full Text] [Related]

  • 25. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Claeys G, Lontie M, Van Meensel B, Herman L, Haesebrouck F, Butaye P.
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [Abstract] [Full Text] [Related]

  • 26. CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents.
    Dolejska M, Frolkova P, Florek M, Jamborova I, Purgertova M, Kutilova I, Cizek A, Guenther S, Literak I.
    J Antimicrob Chemother; 2011 Dec; 66(12):2784-90. PubMed ID: 21954457
    [Abstract] [Full Text] [Related]

  • 27. CTX-M-1-related extended-spectrum beta-lactamases producing Escherichia coli: so far a sporadic event in Western Austria.
    Prelog M, Fille M, Prodinger W, Grif K, Brunner A, Würzner R, Zimmerhackl LB.
    Infection; 2008 Aug; 36(4):362-7. PubMed ID: 18574554
    [Abstract] [Full Text] [Related]

  • 28. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.
    Rogers BA, Sidjabat HE, Paterson DL.
    J Antimicrob Chemother; 2011 Jan; 66(1):1-14. PubMed ID: 21081548
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2.
    Oteo J, Diestra K, Juan C, Bautista V, Novais A, Pérez-Vázquez M, Moyá B, Miró E, Coque TM, Oliver A, Cantón R, Navarro F, Campos J, Spanish Network in Infectious Pathology Project (REIPI).
    Int J Antimicrob Agents; 2009 Aug; 34(2):173-6. PubMed ID: 19464856
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Characterization of extended spectrum β-lactamase-producing Escherichia coli in community-acquired urinary tract infections in Tunisia.
    Hammami S, Saidani M, Ferjeni S, Aissa I, Slim A, Boutiba-Ben Boubaker I.
    Microb Drug Resist; 2013 Jun; 19(3):231-6. PubMed ID: 23363379
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.
    Simner PJ, Zhanel GG, Pitout J, Tailor F, McCracken M, Mulvey MR, Lagacé-Wiens PR, Adam HJ, Hoban DJ, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):326-34. PubMed ID: 21353961
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
    Zhong YM, Liu WE, Liang XH, Li YM, Jian ZJ, Hawkey PM.
    J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
    [Abstract] [Full Text] [Related]

  • 40. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.
    Peirano G, Pitout JD.
    Int J Antimicrob Agents; 2010 Apr; 35(4):316-21. PubMed ID: 20060273
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.